Clear Information for Safer Use

Boston Oncology is committed to helping patients and caregivers find reliable information about our medicines, their safe use, and how to report a concern.

Information About Our Medicines

Explore the portfolio by therapeutic category to find basic product information, including generic and trade names, available strengths, dosage forms, and pack sizes.

Product availability and approved uses may vary. Always follow the instructions provided with your medicine and the guidance of your treating healthcare professional.

Health Across a Lifetime

Health needs change—and often overlap—over time. Boston Oncology’s Lifetime Health Stack™ spans five connected layers: Cancer, Chronic Inflammation, Metabolic Health, Lipids and Cardiovascular Risk, and Neurocognitive Health. Together, they address prevention, long-term disease management, and complex treatment.

The goal is not only to respond when disease becomes urgent, but to support earlier intervention, reliable access to medicine, and treatment that can be sustained over time.

Understanding Generics and Biosimilars

Both are approved by comparison with an existing reference medicine and must meet applicable regulatory standards for quality, safety, and effectiveness. Because conventional medicines and biologic medicines are made differently, the evidence required for approval is also different.

Generic Medicine

What is it?

A medicine containing the same active ingredient as an approved reference medicine. It matches the reference medicine in strength, dosage form, route of administration, and intended use.

How is it compared?

A generic must demonstrate bioequivalence—showing that the active ingredient reaches the body at the same rate and to the same extent as the reference medicine.

What can patients expect?

The same clinical benefit and risks as the reference medicine.

Biosimilar

What is it?

A biologic medicine that is highly similar to an approved reference biologic. Because biologics are produced using living systems, a biosimilar is not an exact molecular copy.

How is it compared?

A biosimilar undergoes a detailed comparison of its structure, function, quality, and clinical performance. Any differences cannot be clinically meaningful.

What can patients expect?

No clinically meaningful differences in safety or effectiveness compared with the reference biologic.

Both generics and biosimilars must be approved by the relevant regulatory authority.

Patients with questions about a prescribed medicine should speak with their healthcare professional.

Questions Worth Asking

Your physician or pharmacist can help you understand how a medicine fits into your care. Useful questions include:

01

Why has this medicine been prescribed for me?

02

How and when should it be used or administered?

03

Could it interact with another medicine or supplement I take?

04

Which side effects should I watch for, and when should I seek help?

05

How should the medicine be stored, and what should I do about a missed dose or unused medicine?

Boston Oncology does not provide individual medical diagnosis or treatment advice through this website. Do not start, stop, or change a medicine without speaking with a qualified healthcare professional.

Using and Storing Medicines Safely

Help Us Monitor the Safety and Quality of Our Medicines

If you experience a suspected side effect, medication error, lack of effectiveness, or product-quality issue involving a Boston Oncology medicine, please report it to our pharmacovigilance team.

Reporting helps us monitor medicine safety and fulfill our responsibilities to patients, healthcare professionals, and regulatory authorities.

Regulatory Commercial ManufacturingRegulatory Commercial ManufacturingRegulatory RequirementsCMC & Quality EvidenceClinical, Access & Market DevelopmentRegulatory ApprovalRegistration PricingBoston Oncology PlatformIntegratedLocalizedAccountableLocal Healthcare MarketProcurementHospital SystemsClincal UseRegulatory Boston Oncology PlatformIntegratedLocalizedAccountableLocal Healthcare MarketLocal Healthcare SystemProcurementHospital SystemsClincal UseRegulatory Commercial Manufacturing Lifecycle Reimb.Regulatory CommercialClinical P&T Warehousing Purchasers Budget & PlanningHospital SystemsTech Transfer Production Supply Planning QualityManufacturing Tender Direct PO MarketplacePurchasing AuthorityPurchase MechanismsInsistutional ApprovalsRegulatory RequirementsCMC & Quality EvidenceClinical, Access & Market DevelopmentRegulatory ApprovalRegistration Pricing Lifecycle Reimb.Regulatory Clinical P&T Warehousing Purchasers Budget & PlanningHospital SystemsTech Transfer Production Supply Planning QualityManufacturing Tender Direct PO MarketplacePurchasing AuthorityPurchase MechanismsInsistutional ApprovalsBatch ReleaseCommercialRegulatory RequirementsCMC & Quality EvidenceClinical, Access & Market DevelopmentRegulatory ApprovalRegistration Pricing Lifecycle Reimb.Regulatory Clinical P&T Warehousing Purchasers Budget & PlanningHospital SystemsTech Transfer Production Supply Planning QualityManufacturing Tender Direct PO MarketplacePurchasing AuthorityPurchase MechanismsInsistutional ApprovalsDemand &Inventory SignalsBatch ReleaseDemand &Inventory SignalsCommercialRegulatory RequirementsCMC & Quality EvidenceClinical, Access & Market DevelopmentRegulatory ApprovalRegistration Pricing Lifecycle Reimb.Regulatory Clinical P&T Warehousing Purchasers Budget & PlanningHospital SystemsTech Transfer Production Supply Planning QualityManufacturing Tender Direct PO MarketplacePurchasing AuthorityPurchase MechanismsInsistutional ApprovalsBatch ReleaseDemand &Inventory Signals Manufacturing Commercial Local Healthcare SystemBoston Oncology PlatformIntegratedLocalizedAccountableLocal Healthcare MarketProcurementHospital SystemsClincal UseRegulatory Manufacturing Commercial Local Healthcare SystemBoston Oncology PlatformIntegratedLocalizedAccountableLocal Healthcare MarketProcurementHospital SystemsClincal UseRegulatory Manufacturing Commercial Local Healthcare SystemScale91 hospitals served1,000+ purchase orders annually+45M units manufacturing capacityIn PracticeLeading immunology therapies achieving full adoption across government hospital systemsIncreased utilization of complex biologic therapies following localized market entryEstablished hospital therapies becoming first-line standards across national treatment networksBenefitsBenefits

Urgent safety notice

If you or someone else may require urgent medical attention, contact local emergency services or a healthcare professional immediately. The online reporting form is not an emergency service.